title: Bisphosphonates and the dental practitioner--a guide to management.
abstract: The author has been managing osteonecrosis of the jaws (ONJ) for more than six years. This paper will outline the dental management of patients taking bisphosphonates. This will include: 1. The predisposing factors causing ONJ, 2. Its clinical presentation, 3. Staging for the appropriate conservative and surgical management, 4. Guidelines for prevention, 5. Case report.
authors: School of Dentistry, University of Western Australia and Maxillofacial Unit, Royal Perth Hospital. raymond.williamson@uwa.edu.au
authors: Raymond
authors: R
authors: Williamson
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003646:Debridement; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced / Q000517:prevention & control / Q000601:surgery*; D008439:Maxillary Diseases / Q000139:chemically induced / Q000601:surgery; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced / Q000517:prevention & control / Q000601:surgery*; D010347:Patient Care Planning; D012307:Risk Factors; D014945:Wound Healing
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates